Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr ...

Test positivity for common cold coronaviruses significantly declined following widespread SARS-CoV-2 infection and COVID-19 ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV.

In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

As many as 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine.

Discover Parsvottanasana, the pyramid pose, which improves balance, leg flexibility, and concentration. A must-do of Iyengar's Light on Yoga Challenge. #IyengarYoga #Parsvottanasana #YogaChallenge #Po ...

RSV is ubiquitous, one of the most common causes of childhood illness. Most kids will catch this highly contagious respiratory virus at some point before they turn 2, according to the CDC.

Key takeaways: The FDA approved the monoclonal antibody clesrovimab-cfor for preventing RSV disease in babies. Unlike nirsevimab, which has weight-based dosing, clesrovimab has a fixed dose.

Results showed the incidence rate of RSV-associated MALRI requiring at least 1 indicator of LRI or severity through 150 days was 3.6% (95% CI, 2.0-6.0) in clesrovimab-treated patients compared ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they ...

Pharma Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus By Kevin Dunleavy Jun 9, 2025 4:33pm Merck respiratory syncytial virus RSV Sanofi ...